July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer
May 30, 2025, 05:52

C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer

C. Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastases Program (PROP) at Princess Margaret Cancer Centre, posted on X:

“Remarkable efforts to obtain on-treatment tissue to study TME.
CRT with sequential pembro *might* be more favorable than concurrent pembro.”

Ttile: Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer

Authors: Dan P. Zandberg, Lazar Vujanovic, David A. Clump, Brian P. Isett, Hong Wang, Gabriel Sica, Riyue Bao, Housayin Li, James Ohr, Heath D. Skinner, Raja R. Seethala, Simion I. Chiosea, Robert L. Ferris, Julie E. Bauman

Read The Full Article at Journal of Clinical Oncology.

C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer

More posts featuring Head and Neck Cancer.